Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-032256

Chairman and CEO bought 1,600 shares at an average $1.38 ($2,202)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-05-22 Purchase +1,000 $1.38 $1,380 10,636,493 D
Niihara Yutaka Chairman and CEO 2020-05-26 Purchase +600 $1.37 $822 10,637,093 D
Open-market purchases · 1,600 sh · avg $1.38 · $2,202
Loading xslF345X03/doc4.xml…